UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A8C6CC17 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A8C6AUH8 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A8C6FDH4 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A4U1EXR4 | Tartrate-resistant acid phosphatase type 5 |
|
1 | 0 |
|
A0A4U1EXQ8 | Potassium channel subfamily K member |
|
1 | 0 |
|
A0A4U1ESU7 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A8C6F8C4 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C6AF75 | N-acetylgalactosamine-6-sulfatase |
|
2 | 0 |
|
A0A4U1FQC8 | ADAM metallopeptidase with thrombospondin type 1 motif 1 |
|
3 | 0 |
|
A0A8C6BV68 | Hyaluronidase |
|
1 | 0 |
|
A0A8C6BV22 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C6B3C1 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A8C6F8C1 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C6CFW9 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A8C6B8X7 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C6BYG1 | Phosphoinositide phospholipase C |
|
2 | 0 |
|
A0A8C6FCJ2 | GDNF family receptor alpha-1 |
|
2 | 0 |
|
A0A8C6BV48 | Potassium channel subfamily K member |
|
1 | 0 |
|
A0A8C6BM99 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C6F2V2 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A8C6BMV1 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C6CHF5 | Hemopexin |
|
1 | 0 |
|
A0A8C6B5B9 | Paraoxonase |
|
2 | 0 |
|
A0A8C6B398 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A8C6FDA8 | Angiotensin-converting enzyme |
|
3 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024